Bone tissue grown outside the body transplanted into arm

“The success of this experimental treatment may lead humanity to a new era in which it will be possible to achieve full recovery in most cases.”

By
August 16, 2017 20:06
1 minute read.
Emek Medical Center

Emek Medical Center 521. (photo credit: Courtesy)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

For the first time in the world, live human bone tissue that was grown outside the body has been successfully transplanted into a person’s arm, thanks to a still-experimental procedure developed by an Israeli company.

Because of the importance of the announcement, the Tel Aviv Stock Exchange halted fixed trade in the company’s stock for 15 minutes; sales resumed at 10:05 a.m., when its price rose by 13%.

Be the first to know - Join our Facebook page.


The transplant was carried out by injection at Afula’s Emek Medical Center, as part of a clinical trial of the BioGroup Bonus company.

Dr. Shai Mertzky, CEO of BioGroup Bonus, noted that “transplantation of human bone tissue into a patient who has suffered a major critical deficiency in the bone of his arm sets a new standard of hope for rapid healing in a wide variety of cases. This was the only solution for the patient when nothing else helped.

“The success of this experimental treatment may lead humanity to a new era in which it will be possible to achieve full recovery in most cases,” he said.


BioGroup is a Haifa-based biotech company specializing in tissue engineering and developing a unique technology for the implantation of human bone grafts for transplantation in humans.

The live implant of human bone was produced in the company’s production laboratory in Haifa, under sterile and controlled conditions. It simulated the conditions required for bone production in the human body within two weeks after a fat tissue sample was taken from the patient.

The first patient is an Israeli man in his 40s who, as a result of a serious car accident several years ago, suffered significant bone loss in his arm. Before this transplant, the patient had undergone several operations in which the missing bone could not be replaced, and the possibility of cutting off part of his forearm had been considered.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Workers strike outside of the Teva building in Jerusalem, December 2017
December 18, 2017
Workers make explosive threats as massive Teva layoff strikes continue

By MAX SCHINDLER